Metformin treatment decreased NLK expression and recapitulated the phenotype observed by NLK knockdown, indicating that NLK may be a contributing factor and underlying mechanism for the inhibition of growth and stemness observed in lung cancer cells. Here, NLK is linked to lung carcinoma.